IL150787A0 - Semi-synthetic taxanes with antitumor and antiangiogenetic activities - Google Patents

Semi-synthetic taxanes with antitumor and antiangiogenetic activities

Info

Publication number
IL150787A0
IL150787A0 IL15078701A IL15078701A IL150787A0 IL 150787 A0 IL150787 A0 IL 150787A0 IL 15078701 A IL15078701 A IL 15078701A IL 15078701 A IL15078701 A IL 15078701A IL 150787 A0 IL150787 A0 IL 150787A0
Authority
IL
Israel
Prior art keywords
del
ins
sup
delete
date
Prior art date
Application number
IL15078701A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of IL150787A0 publication Critical patent/IL150787A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15078701A 2000-01-18 2001-01-15 Semi-synthetic taxanes with antitumor and antiangiogenetic activities IL150787A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000056A IT1317731B1 (it) 2000-01-18 2000-01-18 Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.
PCT/EP2001/000386 WO2001053282A1 (en) 2000-01-18 2001-01-15 Semi-synthetic taxanes with antitumor and antiangiogenetic activities

Publications (1)

Publication Number Publication Date
IL150787A0 true IL150787A0 (en) 2003-02-12

Family

ID=11443708

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15078701A IL150787A0 (en) 2000-01-18 2001-01-15 Semi-synthetic taxanes with antitumor and antiangiogenetic activities

Country Status (24)

Country Link
US (2) US6589979B2 (cs)
EP (1) EP1248776B1 (cs)
JP (1) JP4986354B2 (cs)
KR (1) KR100813704B1 (cs)
CN (1) CN1176916C (cs)
AT (1) ATE271044T1 (cs)
AU (1) AU781650B2 (cs)
CA (1) CA2397591C (cs)
CZ (1) CZ301251B6 (cs)
DE (1) DE60104281T2 (cs)
DK (1) DK1248776T3 (cs)
ES (1) ES2223778T3 (cs)
HK (1) HK1049998B (cs)
HU (1) HU229347B1 (cs)
IL (1) IL150787A0 (cs)
IT (1) IT1317731B1 (cs)
NO (1) NO329403B1 (cs)
PL (1) PL202591B1 (cs)
PT (1) PT1248776E (cs)
RU (1) RU2259363C2 (cs)
SI (1) SI1248776T1 (cs)
SK (1) SK285683B6 (cs)
TR (1) TR200401811T4 (cs)
WO (1) WO2001053282A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688415A1 (en) * 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
ITMI20050415A1 (it) * 2005-03-15 2006-09-16 Indena Spa Derivati tassanici semi-sintetici ad attivita' antitumorale
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 荷電連結体及び共役体のためのその使用
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
AU684218B2 (en) * 1994-07-26 1997-12-04 Indena S.P.A. Semi-synthetic taxanes with anti-tumoural activity

Also Published As

Publication number Publication date
USRE39723E1 (en) 2007-07-10
US6589979B2 (en) 2003-07-08
KR100813704B1 (ko) 2008-03-13
ATE271044T1 (de) 2004-07-15
JP4986354B2 (ja) 2012-07-25
HUP0204344A2 (en) 2003-05-28
TR200401811T4 (tr) 2004-09-21
HK1049998B (zh) 2005-04-01
NO329403B1 (no) 2010-10-11
EP1248776A1 (en) 2002-10-16
KR20020068082A (ko) 2002-08-24
ES2223778T3 (es) 2005-03-01
PT1248776E (pt) 2004-10-29
SK285683B6 (sk) 2007-06-07
ITMI20000056A0 (it) 2000-01-18
ITMI20000056A1 (it) 2001-07-18
CZ20022478A3 (cs) 2002-10-16
CZ301251B6 (cs) 2009-12-23
RU2002119060A (ru) 2004-01-10
PL356272A1 (en) 2004-06-28
SI1248776T1 (en) 2004-10-31
IT1317731B1 (it) 2003-07-15
EP1248776B1 (en) 2004-07-14
WO2001053282A1 (en) 2001-07-26
AU3369401A (en) 2001-07-31
HU229347B1 (hu) 2013-11-28
NO20023428L (no) 2002-09-16
HUP0204344A3 (en) 2004-01-28
CA2397591C (en) 2009-10-20
PL202591B1 (pl) 2009-07-31
HK1049998A1 (en) 2003-06-06
JP2003520792A (ja) 2003-07-08
NO20023428D0 (no) 2002-07-17
AU781650B2 (en) 2005-06-02
DE60104281D1 (de) 2004-08-19
DK1248776T3 (da) 2004-11-22
CN1395571A (zh) 2003-02-05
CN1176916C (zh) 2004-11-24
CA2397591A1 (en) 2001-07-26
DE60104281T2 (de) 2005-08-18
RU2259363C2 (ru) 2005-08-27
US20030028038A1 (en) 2003-02-06
SK10562002A3 (sk) 2002-11-06

Similar Documents

Publication Publication Date Title
TR200200717T2 (tr) Terapötik kinazolin türevleri.
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
EP1154782A4 (en) TAXAN DERIVATIVES FOR TARGETED CANCER THERAPY
DE69728152D1 (en) Hoch-lipophile campothecin-derivate
GB2334521A (en) Anthranilic acid derivatives as multi drug resistance modulators
PL367682A1 (en) Dolastatin 10 derivatives
EP1017675A4 (en) HIGHLY LIPOPHILIC CAMPTOTHECIN DERIVATIVES
PL364811A1 (en) Indolyl-3-glyoxylic acid derivatives serving as antitumor agents
BG104436A (en) The administration of macrolides for the treatment of cancer and macular degeneration
ATE238981T1 (de) Antitumorwirkstoffe
MY129310A (en) C-4 carbonate taxanes
DE60205455T2 (de) Naphthyridinderivate
SI1248776T1 (en) Semi-synthetic taxanes with antitumor and antiangiogenetic activities
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
MX2007001267A (es) Derivados de naftiridinas 2,8-disustituidas.
EE200200681A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
Su et al. Antitumor therapeutic effects of new gene-targeted alkylating agents, 9-anilinoacridines bearing an alkylating N-mustard residue on the acridine chromophore

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed